• 제목/요약/키워드: B Hepatitis

검색결과 765건 처리시간 0.024초

등온증폭반응법과 변성 고성능 액체 크로마토그래피를 이용한 B형 간염 바이러스의 검출 (Detection of Hepatitis B Virus by LAMP and DHPLC)

  • 안영창;서재원;최재구;장원철
    • 대한화학회지
    • /
    • 제55권2호
    • /
    • pp.262-267
    • /
    • 2011
  • 형광 검출기를 기반으로 한 변성 고성능 액체 크로마토그래피(DHPLC)분석법은 핵산검출에 유용하게 사용되고 있으며 또한 등온증폭 반응법은 병원성 미생물의 효과적인 검출방법으로 알려져 있다. 이 연구에서는 HBV의 조기 분석 방법으로써 사용되는 등온증폭반응법(LAMP)과 변성고성능 액체 크로마토그래피(DHPLC)의 검출한계와 특이성, 그리고 민감도를 평가하였다. 등온증폭 반응법의 검출 시간이 가장 빠른 장점을 보였으나, 변성 고성능 액체 크로마토그래피 분석법이 등온증폭반응법과 real-time PCR분석법과 비교한 결과, 10배 이상의 높은 민감도를 확인 할 수 있었다. 본 결과로서 B형 간염 바이러스의 진단을 위하여, 빠른 검출법으로써 등온증폭 반응법이 유용하게 쓰일 수 있을 것이며 변성 고성능 액체 크로마토그래피 분석법은 좀 더 낮은 병원균의 감염도 검출할 수 있어, 임상에서 유용하게 사용할 수 있을 것이다.

Lack of Association of BIRC5 Polymorphisms with Clearance of HBV Infection and HCC Occurrence in a Korean Population

  • Lee, Jin-Sol;Kim, Jeong-Hyun;Park, Byung-Lae;Cheong, Hyun-Sub;Kim, Jason-Y.;Park, Tae-Joon;Chun, Ji-Yong;Bae, Joon-Seol;Lee, Hyo-Suk;Kim, Yoon-Jun;Shin, Hyoung-Doo
    • Genomics & Informatics
    • /
    • 제7권4호
    • /
    • pp.195-202
    • /
    • 2009
  • BIRC5 (Survivin) belongs to the inhibitor of apoptosis gene family. The BIRC5 protein inhibits caspases and consequently blocks apoptosis. Thus, BIRC5 contributes to the progression of cancer allowing for continued cell proliferation and survival. In this study, we identified eight sequence variants of BIRC5 through direct DNA sequencing. Among the eight single nucleotide polymorphisms (SNPs), six common variants with frequencies higher than 0.05 were selected for larger-scale genotyping (n=1,066). Results of the study did not show any association between the promoter region polymorphisms and the clearance of hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) occurrence. This is in line with a previous study in which polymorphisms in the promoter region does not influence the function of BIRC5. Initially, we were able to detect a signal with the +9194A>G, which disappeared after multiple corrections but led to a change in amino acid. Similarly, we were also able to detect an association signal between two haplotypes (haplotype-2 and haplotype-5) on the onset age of HCC and/or HCC occurrence, but the signals also disappeared after multiple corrections. As a result, we concluded that there was no association between BIRC5 polymorphisms and the clearance HBV infection and/or HCC occurrence. However, our results might useful to future studies.

Hepatitis C Virus Nonstructural 5A Protein (HCV-NS5A) Inhibits Hepatocyte Apoptosis through the NF-κb/miR-503/bcl-2 Pathway

  • Xie, Zhengyuan;Xiao, Zhihua;Wang, Fenfen
    • Molecules and Cells
    • /
    • 제40권3호
    • /
    • pp.202-210
    • /
    • 2017
  • The nonstructural protein 5A (NS5A) encoded by the human hepatitis C virus (HCV) RNA genome is a multifunctional phosphoprotein. To analyse the influence of NS5A on apoptosis, we established an Hep-NS5A cell line (HepG2 cells that stably express NS5A) and induced apoptosis using tumour necrosis factor $(TNF)-{\alpha}$. We utilised the MTT assay to detect cell viability, real-time quantitative polymerase chain reaction and Western blot to analyse gene and protein expression, and a luciferase reporter gene experiment to investigate the targeted regulatory relationship. Chromatin immunoprecipitation was used to identify the combination of $NF-{\kappa}B$ and miR-503. We found that overexpression of NS5A inhibited $TNF-{\alpha}$-induced hepatocellular apoptosis via regulating miR-503 expression. The cell viability of the $TNF-{\alpha}$ induced Hep-mock cells was significantly less than the viability of the $TNF-{\alpha}$ induced Hep-NS5A cells, which demonstrates that NS5A inhibited $TNF-{\alpha}$-induced HepG2 cell apoptosis. Under $TNF-{\alpha}$ treatment, miR-503 expression was decreased and cell viability and B-cell lymphoma 2 (bcl-2) expression were increased in the Hep-NS5A cells. Moreover, the luciferase reporter gene experiment verified that bcl-2 was a direct target of miR-503, NS5A inhibited $TNF{\alpha}$-induced $NF-{\kappa}B$ activation and $NF-{\kappa}B$ regulated miR-503 transcription by combining with the miR-503 promoter. After the Hep-NS5A cells were transfected with miR-503 mimics, the data indicated that the mimics could reverse $TNF-{\alpha}$-induced cell apoptosis and blc-2 expression. Collectively, our findings suggest a possible molecular mechanism that may contribute to HCV treatment in which NS5A inhibits $NF-{\kappa}B$ activation to decrease miR-503 expression and increase bcl-2 expression, which leads to a decrease in hepatocellular apoptosis.

B형 간염 바이러스 만성 감염 소아의 추적 관찰 (Follow-up of Children with Chronic Hepatitis B Virus Infection)

  • 황성현;김종현;강진한;허재균;이경일;오진희;이승희;고대균
    • Pediatric Infection and Vaccine
    • /
    • 제11권1호
    • /
    • pp.73-80
    • /
    • 2004
  • 목 적 : 소아 HBV 만성 감염 환자들에 대한 연속적인 임상적 소견, 생화학 검사 및 혈청학적 표지자의 변화를 분석하여 이들간의 연관성을 알아보았다. 방 법 : 1995년 7월 1일부터 2000년 6월 30일까지 5년간 가톨릭대학교 성빈센트병원 소아과를 방문하여 6개월 이상 추적이 가능하였던 HBV 만성감염 소아 90명을 대상으로 하였다. 이들 모두는 HBV 표지자인 HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc IgG와 간기능 검사를 시행하였다. 결 과 : 첫 내원시 대상 모두가 무증상이었고 HBV 만성 감염의 가족력이 83%에서 있었다. HBeAg 양성이 81%, HBeAg 음성, anti-HBe 양성이 16%, HBeAg, anti-HBe 모두 음성인 경우가 3%로 성별간의 차이는 없었고, 대상군의 연령을 0~5, 6~10, 11~15세로 나누었을 때 HBeAg 양성은 각각 90%, 96%, 61%로 10세 이하의 양성률이 11~15세에 비해 의미있게 높았다(P=0.001). 혈청 ALT치는 40 IU/L 이하, 41~80 IU/L, 81~200 IU/L, 201 IU 이상인 경우가 각각 64%, 17%, 10%, 9%이었고 HBeAg 양성군이 음성군에 비해 ALT의 비정상인 경우가 의미있게 많았다(P=0.036). HBeAg에서 anti-HBe로 전환된 경우가 73명 중 11명에서 발생하였고 이들 모두에서 anti-HBe의 전환 전에 ALT치의 증가가 관찰되었다. HBeAg 및 HBsAg의 연간 자연소실율은 각각 9.7%, 0.6%이었다. 결 론 : HBV 표지자 및 생화학적 검사치의 변화양상을 숙지하는 것은 이와 관련된 연구를 시행할 때 대상을 선정하고 또한 질환에 대한 치료 여부, 치료제의 선택 및 효과를 검토할 때 필요한 사항이며 각 개인의 HBV 만성 감염의 악화 예후인자를 찾기 위하여 증상이 없더라도 보유자에 대한 계속적인 관찰은 매우 중요하다고 생각된다.

  • PDF

수도권 치과의료 종사자들의 B형 간염에 대한 기초방호실태 및 수행에 관한 조사 (A Survey of the Basic Protection Manners of Dental Personnels Against Hepatitis B in and around Seoul)

  • 윤미숙;박미영
    • 치위생과학회지
    • /
    • 제1권1호
    • /
    • pp.46-52
    • /
    • 2001
  • 2001년 3월 29일부터 2001년 5월 9일까지 서울 경기지역 건강사회를 위한 치과의사회에 소속되어 있는 치과의원과 치과병원에 근무하는 치과위생사 78명과 치과조무사 50명을 대상으로 설문조사를 실시하였다. 조사 내용은 일반적 특성, 자가 건강관리, 개인방호의 실천, 치과진료기구의 취급, 손 씻기에 관한 사항으로 구성되어 있다. 일반적 특성과 요인들간의 관계를 비교 관찰한 연구결과는 다음과 같다. 1. 병원 근무 전 건강검진을 받은 경우는 근무년수 5-7년 미만이 71.4%로 가장 많았고, 병원 근무 후 건강검진을 받은 경우는 근무년수 9년 이상이 61.5%로 가장 높았음을 알 수 있었다(P<0.05). 2. 병원 근무 후 B형 간염예방접종을 받은 경우는 연령별로는 35세 이상이 71.4%로 가장 많았고, 근무년수별로는 9년 이상이 57.7%로 가장 많게 나타나 연령과 근무년수에 따라 차이를 보였다(P<0.05). 3. 개인방호실천은 치과위생사와 치과조무사 사이에 유의한 차이는 없었다(P>0.05). 그러나 개인방호 실천도를 3점 만점으로 할 때 마스크 착용 2.40과 장갑착용 1.96에 비해 진료용 보안경 착용 1.48로 낮게 사용되고 있음을 알 수 있었다. 4. 사용하고 남은 마취제의 관리는 1회 사용 후 버리는 경우가 치과위생사는 89.7%, 치과조무사 70.0%로 치과위생사에서 높게 나타났다(P<0.05). 5. 손 세정제로 항균용 액체비누를 쓰는 치과위생사가 19.3%, 치과조무사 10.0%로 매우 낮았으며, 손 건조 방법으로 1회용 종이수건을 사용하는 치과위생사 37.2%, 치과조무사 36.0%로 낮게 나타났다(P>0.05).

  • PDF

B형간염(型肝炎) 표면항원(表面抗原)의 주면역원(主免疫原) 결정기(決定基)에 특이(特異)한 합성(合成) Peptide의 면역원성(免疫原性)에 관한 연구(硏究) (Immunogenicity of Synthetic Peptide Specific for Major Immunogenic Determinat of Hepatitis B Surface Antigen)

  • 신광순;한수남
    • 대한수의학회지
    • /
    • 제25권1호
    • /
    • pp.7-17
    • /
    • 1985
  • Many investigators have been pursuing various attempts so far to produce hepatitis B surface antigen(HBsAg) vaccines using the techniques such as isolation from plasma of chronic HBsAg carrier, recombinant DNA technique or preparation of synthetic peptides specific for immunogenic determinants. Hepatitis B virus can not grow on any cell lines by the tissue culture technique at the present time. The plasma of chronic HBsAg carrier is expensive and its source is limited. The HBsAg from the recombinant DNA technique gave still very low yield. Another approach, therefore, has been initiated to develop a synthetic hepatitis B virus vaccine. The possible use of several distinct synthetic vaccines in prophylaxis can be facilitated by availability of full synthetic immunogens. Peptides synthesized for potential application as antiviral vaccines have been mostly tested in the form of conjugates with carrier proteins, although the free synthetic peptide can be immunogenic. To understand basic knowledges on the antigenicity and immunogenicity of a synthetic peptide specific for major immunogenic determinant of HBsAg, a nonapeptide, $H_2N^{139}Cys-Thr-Lys-Pro-Thr-Asp-Gly-^{146}Asn-Aba$ COOH, which corresponds to HBsAg amino acid residues 139 to 147, was synthesized by the Merrifield's solid-phase method with a slight modification. The antigenicity and immunogenicity of this specific synthetic peptide were examined comparing with purified plasma-derived natural HBsAg. The results obtained are as follows; 1. The peptide synthesized showed the identical amino acid composition to the theoretical value. The degree of purification and molecular weight were acertained by methods of high performance liquid chromatography and mass spectrometry. 2. Using m-maleimidobenzoyl-N-hydroxysuccinimide ester as a conjugating agent, the synthetic peptide was conjugated to rabbit albumin and ${\gamma}$-globulin, tetanus and diphtheria toxoids, and keyhole limpet hemocyanin. Their conjugation yields were 8.3, 9.5, 15.8, 13.5, and 11.2%, respectively. 3. The natural HBsAg was purified from plasma of chronic HBsAg carrier. By the electron microscopic observation of the purified natural HBsAg preparation, no Dane particles were observed and the preparation showed negative DNA polymerase activity. 4. Antigenicity of the synthetic peptide and the plasma-derived natural HBsAg was determined by competition radioimmunoassay using $^{125}I$-natural HBsAg. Their 50% inhibitions appeared as $90{\mu}g/ml$ and $0.12{\mu}g/ml$ for the synthetic peptide and the natural HBsAg, respectively. This indicates that the former was about 750-fold less antigenic than the latter. 5. Immunogenicity of the synthetic peptide was determined by administering the peptide-carrier conjugates into rabbits with and without Freund's complete adjuvant. Regardless the carrier proteins and adjuvant, positive immune responses to the synthetic peptide were observed. The higher antibody titers, however, were shown in the groups administered with Freund's complete adjuvant. 6. Immunizing dose 50% in mice of the various peptide-carrier conjugates was 5.47, 6.00, 65.16, 31.25 and $13.03{\mu}g/dose$ for rabbit albumin and ${\gamma}$-globulin, tetanus and diphtheria toxoids, and keyhole limpet hemocyanin, respectively, while the natural HBsAg showed $0.65{\mu}g/dose$. 7. It was postulated that homologous proteins prefer to heterologous ones as the carriers.

  • PDF

가족집적성을 보이는 B형간염 바이러스 만성보유자에서 바이러스 유전자의 돌연변이와 주조직접합체 양상 - 질병발현 형태와의 관련성을 중심으로 - (Hepatitis B Virus DNA Mutation, Pattern of Major Histocompatibility Class-I among Familial Clustered HBV Carriers in Relation to Disease Progression)

  • 정승필;이효석;김정룡;안윤옥
    • Journal of Preventive Medicine and Public Health
    • /
    • 제33권3호
    • /
    • pp.323-333
    • /
    • 2000
  • Objectives : Chronic HBsAg carriers are the principal source of infection for other susceptible people, and are themselves at high risk of developing serious liver diseases. In Korea, it has been estimated that 65-75% of the HBsAg positives remained as persistent carriers. Additionally, familial clustering of MBV infection has frequently been observed among carriers. Some would become progressive, chronic hepatitis patients, and others would not. The aim of this study was to evaluate the association between various factors, such as the duration of infection, type of virus, mutation of precore/core region in HBV, major histocompatibility class-I, and developing chronic liver diseases among familial HBV carriers. Methods : Chronic carrier status was identified by repeated serological tests for HBsAg at intervals of six months or more. A familial chronic carrier was defined when the disease was observed in a family member over two generations. Two families were recruited, among which a total of 20 chronic HBsAg carriers(11 carriers in No.1, and 9 in No.2 family) were identified. Data on the general characteristics and liver disease status were collected. Identification of the HBV-DNA was successful only for 13 subjects among the 20 carriers. Analysis of viral DNA in terms of subtype, pre-core and core region mutations was carried out. The type of major histocompatibility class-1 for the 13 subjects was also analysed. Results & Conclusions : Seven of 10 chronic HBV carriers of the 1st generation and one of 10 of the 2nd generation were clinical patients with chronic hepatitis, the others, three of the 1 st and nine of the 2nd generation, were asymptomatic carriers. This data indicates that the duration of HBV carriage is one of the major factors for disease severity. The subtype of HBsAg analysed using MBV-DNA identified in 13 carriers were adr, and the pattern of precore nonsense mutation in HBV-DNA was identical among family members, which meads that the same virus strains were transmitted between the family members. The association between the precore or core mutations in HBV-DNA and the disease severity was not observed. While it was suggested that a specific type of MHC class-I may be related to disease progression.

  • PDF

C형 간염의 진단을 위한 역전사중합효소연쇄반응과 효소면역측정법의 타당성 평가 (Assessment of Validity of RT-PCR and EIA for The Detection of Hepatitis C Virus Infection)

  • 손병철;전진호;박영홍;신해림;조규일;김종한;정귀옥;이종태;이채언;백낙환
    • Journal of Preventive Medicine and Public Health
    • /
    • 제28권2호
    • /
    • pp.526-541
    • /
    • 1995
  • This study was conducted to estimate the validity of reverse transcriptase-polymerase chain reaction(RT-PCR) compared to enzyme immunoassay(EIA) for the detection of hepatitis C virus (HCV) infection. EIA for antibody to HCV(anti-HCV) and RT-PCR for HCV was executed on the subjects from Pusan and Kyungnam area with questionnaire survey to collect some relating factors of HCV infection. As the result from 617 cases, the prevalence of HCV infection was 1.5% by EIA and 3.7% by RT-PCR(p<0.05), and the age standardized rate was 1.7% and 3.4% by EIA and RT-PCR, respectively. The prevalence of hepatitis B surface antigen(HBsAg) was 6.8% by enzyme linked immunosorbent assay(ELISA) and the age standardized rate was 7.7%. It was the higher in male group comparing to female group(p<0.01). Both of the prevalence of HCV and HBsAg were higher in elevated asparate aminotransferase(AST) and alanine aminotransferase (ALT) group than in normal AST and ALT group(p<0.01). There was no specific risk factor of HCV infection. Though the degree of agreement of EIA and RT-PCR by gamma statistics was 97.2%, it showed a significant difference between the two methods(p<0.01). For the detection of HCV infection, positive predictive value of EIA was 66.7% and negative predictive value of EIA was 97.2%. This study suggests that negative result to anti-HCV by EIA didn't mean the free state of HCV infection, therefore it would be helpful that further monitoring for HCV infection by RT-PCR in the case of elevated AST and ALT and/or clinically suspected.

  • PDF

대계(大薊)의 주성분인 Silibinin이 알레르기 염증반응에 미치는 효과(效果) (The Effect of Silibinin Extracted from Cirsium Japonicum on Allergic Inflammation)

  • 김범락;김경준
    • 한방안이비인후피부과학회지
    • /
    • 제23권1호
    • /
    • pp.44-58
    • /
    • 2010
  • Silibinin is the major active molecule of silymarin, the mixture of flavonolignans extracted from Cirsium japonicum (CJ). It has been used for treatment of hepatitis and inflammation related diseases. The aim of this study was to prove whether Silibinin has effectiveness for allergic inflammation. Silibinin processes the inflammatory reaction in phorbol 12-myristate 13-acetate (PMA) plus calcium ionophore A23187 (PMA plus A23187) stimulated human mast cell line (HMC-1). Its effect was examined by ELISA, RT-PCR, Western blot, and Luciferase assay. The results were Silibinin inhibited the expression of histamine, TNF-$\alpha$ (tumor necrosis factor-$\alpha$), IL-6 (interleukin-6), and IL-8 (interleukin-8). Silibinin suppressed NF-${\kappa}B$ (nuclear factor kappa B) activation in stimulated HMC-1 (human mast cell-1). This effect was mediated through inhibition of phosphorylation and degradation of $IkB{\alpha}$, an inhibitor of NF-kB. Silibinin significantly inhibited induction of NF-kB promoter mediated Luciferase assay. These results suggest that Silibinin has a potential molecule for therapy of mast cell-derived allergic inflammatory diseases.

치위생과 학생들의 B형 간염 바이러스의 표지자와 인지도에 관한 연구 (A Study on occurrence rates from serologic marker of hepatitis B virus and on perception in dental hygiene students)

  • 강은주;신상희;장선희
    • 한국학교보건학회지
    • /
    • 제15권2호
    • /
    • pp.183-191
    • /
    • 2002
  • This study is aimed at offering basic data about prevention of Hepatitis B virus and infection control to dental hygiene students who will work mostly at dental offices which are characteristically exposed to a high risk of HBV infection. For this study, surveyed were 188 sophomores and juniors of the dental hygiene department who volunteered to undergo the tests of HBsAg and HBsAb. The examination of the blood collected from the samples and analysis of their perception about hygiene resulted in following conclusion: Positive HBsAg Four was found in 4 testees(2.1%) while 118(62.8%) revealed positive HBsAb. Juniors showed higher positive rate in HBsAg whereas sophomores had higher positive rate in HBsAb. But such difference has statistically no significance. Generally, students seemed to pay little attention to HBV, judging from the survey of their perception about the present state of HBsAg and HBsAb(p>0.05), conduct of infection(p<0.05), completion of 3 requested vaccinations(p>0.05), and formation of antibody(p>0.05). With regard to the infection routes of HBV, most students(92.4%) replied "through blood", which is statistically insignificant, though. Next ratio goes to the reply "through contaminated injectors". This reply came more from sophomores than from juniors, a difference which is statistically significant(p<0.05). The lowest rate of possible infection(29.2%) was thought to be "through breast-feeding of a positive mother"(p<0.05). In general, it turned out that sophomores had more knowledge about the infection routes of HBV than juniors. In terms of clinical history among family members, 6(3.1%) reported that some of their family members are currently suffering from a liver complaint, 3(1.6%) replied their family members were once afflicted, and 4(2.1%) said their members died of hepatitis. Except 10(4.7%), all the surveyees replied that their states of health are better than normal. Generally, sophomores are healthier than juniors except for the very health case, a difference which is statistically of no value.